approval
saveDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMar 10, 2026 · 209d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMay 6, 2022 · 1613d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalAug 12, 2019 · 2611d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalMar 29, 2016 · 3842d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDec 28, 2015 · 3934d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalOct 9, 2015 · 4014d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalApr 16, 2015 · 4190d ago
- approvalDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalJan 22, 2015 · 4274d ago
comments(0)
5-min edit window · permanent after that